Dr Roberto Valcavi

Dr. Roberto Valcavi is a specialist in Endocrinology and a specialist in Internal Medicine.

In 1983 he attended the “Department of Endocrinology” directed by Prof. Reginald Hall at the University of Wales (UK). Since 1990 he has been an active member of the SIUMB (Italian Society of Ultrasound in Medicine and Biology) and has directed the SIUMB training on thyroid ultrasound.

Since 1986 he has been in charge of the Endocrine Unit of the IRCCS-Arcispedale Santa Maria Nuova in Reggio Emilia. He started practicing thyroid ablative therapies as early as 1992. From 1996 to 2014 he was Director of the Department of Endocrinology at (IRCCS – ASMN) in Reggio Emilia.

In 1999 he founded the AME (Italian Association of Endocrinologists). In 2001 he held the 1st Joint Meeting AME – AACE (American Association of Clinical Endocrinologists) in Reggio Emilia and was elected President of AME. In 2003 he hosted at the IRCCS – ASMN a delegation from the Endocrine Department of the Mayo Clinic, Rochester, MN, USA, which participated in a joint meeting between the ASMN – Mayo Clinic Thyroid Diseases Centers.

In 2004 in Boston he received the “International Clinician Award” in recognition of the progress achieved in favor of clinical endocrinology and for the benefit of all endocrine patients.

Since 2000 he has attended distinguished US institutions including the Mayo Clinic, Rochester, MN. Since November 2020 Roberto Valcavi is Health Director of the E.T.C. (Endocrine Thyroid Clinic) of Reggio Emilia dedicated in particular to the diagnosis and therapy of the endocrine neck (thyroid, parathyroid, lymph nodes) benign and malignant lesions.

He specializes in ultrasound-guided ablative therapy of radiofrequency thyroid nodules (RFA), minimally invasive surgery capable of effectively treating over 90% of benign thyroid nodules and over 80% of malignant thyroid nodules, saving the thyroid. Dr. Roberto Valcavi is President-in-Office of the T.N.T. (International Association of Thyroid Nodule Therapies).


0 +
PubMed indexed publications



INTRODUCTION Graves Basedow’s disease is the most frequent cause of hyperthyroidism with incidence between 1.5 and 3% of the population. Graves Basedow’s disease mainly affects

Read More »